Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Vaughan, DE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 92 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Brown, NJ; Murphey, LJ; Srikuma, N; Koschachuhanan, N; Williams, GH; Vaughan, DE
      Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigen

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    2. Wilsdorf, T; Gainer, JV; Murphey, LJ; Vaughan, DE; Brown, NJ
      Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm

      HYPERTENSION
    3. Gainer, JV; Stein, CM; Neal, T; Vaughan, DE; Brown, NJ
      Interactive effect of ethnicity and ACE insertion/deletion polymorphism onvascular reactivity

      HYPERTENSION
    4. Kaikita, K; Fogo, AB; Ma, LJ; Schoenhard, JA; Brown, NJ; Vaughan, DE
      Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition

      CIRCULATION
    5. Murphey, LJ; Hachey, DL; Vaughan, DE; Brown, NJ; Morrow, JD
      Quantification of BK1-5, the stable bradykinin plasma metabolite in humans, by a highly accurate liquid-chromatographic tandem mass spectrometric assay

      ANALYTICAL BIOCHEMISTRY
    6. Vaughan, DE
      Angiotensin, fibrinolysis, and vascular homeostasis

      AMERICAN JOURNAL OF CARDIOLOGY
    7. Vaughan, DE
      Plasminogen activator inhibitor-1 and vascular disease in diabetes mellitus

      DIABETES AND CARDIOVASCULAR DISEASE
    8. Vaughan, DE; Jacobson, SH; Armstrong, DE
      A new neighborhood function for discrete manufacturing process design optimization using generalized hill climbing algorithms

      JOURNAL OF MECHANICAL DESIGN
    9. Brown, NJ; Nakamura, S; Ma, LJ; Nakamura, I; Donnert, E; Freeman, M; Vaughan, DE; Fogo, AB
      Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo

      KIDNEY INTERNATIONAL
    10. Nakamura, S; Nakamura, I; Ma, LJ; Vaughan, DE; Fogo, AB
      Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo

      KIDNEY INTERNATIONAL
    11. Coats, SR; Covington, JW; Su, M; Pabon-Pena, LM; Eren, M; Hao, Q; Vaughan, DE
      SSeCKS gene expression in vascular smooth muscle cells: Regulation by angiotensin II and a potential role in the regulation of PAI-1 gene expression

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    12. Brown, NJ; Kim, KS; Chen, YQ; Blevins, LS; Nadeau, JH; Meranze, SG; Vaughan, DE
      Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    13. Murphey, LJ; Gainer, JV; Vaughan, DE; Brown, NJ
      Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin

      CIRCULATION
    14. Vaughan, DE; Brown, NJ
      Effects of acute angiotensin II type 1 receptor antagonism and angiotensinconverting enzyme inhibition on plasma fibrinolytic parameters in patientswith heart failure

      CIRCULATION
    15. Brown, NJ; Gainer, JV; Murphey, LJ; Vaughan, DE
      Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B-2 receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway

      CIRCULATION
    16. Vaughan, DE
      AT(1) receptor blockade and atherosclerosis - Hopeful insights into vascular protection

      CIRCULATION
    17. Venkov, CD; Myers, PR; Tanner, MA; Su, M; Vaughan, DE
      Ethanol increases endothelial nitric oxide production through modulation of nitric oxide synthase expression

      THROMBOSIS AND HAEMOSTASIS
    18. Brown, NJ; Agirbasli, M; Vaughan, DE
      Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans

      HYPERTENSION
    19. Brown, NJ; Gainer, JV; Stein, CM; Vaughan, DE
      Bradykinin stimulates tissue plasminogen activator release in human vasculature

      HYPERTENSION
    20. Limbird, LE; Vaughan, DE
      Augmenting beta receptors in the heart: Short-term gains offset by long-term pains?

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    21. VAUGHAN DE
      PLASMINOGEN-ACTIVATOR INHIBITOR-1 - A COMMON DENOMINATOR IN CARDIOVASCULAR-DISEASE

      Journal of investigative medicine
    22. STEIN CM; BROWN N; VAUGHAN DE; LANG CC; WOOD AJJ
      REGULATION OF LOCAL TISSUE-TYPE PLASMINOGEN-ACTIVATOR RELEASE BY ENDOTHELIUM-DEPENDENT AND ENDOTHELIUM-INDEPENDENT AGONISTS IN HUMAN VASCULATURE

      Journal of the American College of Cardiology
    23. VAUGHAN DE
      FIBRINOLYTIC BALANCE, THE RENIN-ANGIOTENSIN SYSTEM AND ATHEROSCLEROTIC DISEASE

      European heart journal
    24. BROWN NJ; GAINER JV; VAUGHAN DE
      BRADYKININ IS A POTENT, SELECTIVE, AND FLOW-INDEPENDENT STIMULUS OF T-PA RELEASE IN HUMANS

      Hypertension
    25. Brown, NJ; Agirbasli, MA; Williams, GH; Litchfield, WR; Vaughan, DE
      Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1

      HYPERTENSION
    26. Roselli, HT; Su, M; Washington, K; Kerins, DM; Vaughan, DE; Russell, WE
      Liver regeneration is transiently impaired in urokinase-deficient mice

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    27. FOGO AB; VAUGHAN DE
      COMPOUND INTEREST - ACE AND PAI-1 POLYMORPHISMS AND RISK OF THROMBOSIS AND FIBROSIS

      Kidney international
    28. TANG H; KERINS DM; HAO Q; INAGAMI T; VAUGHAN DE
      THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR MEDIATES TYROSINE PHOSPHORYLATION OF FOCAL ADHESION PROTEINS AND ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE IN CULTURED ENDOTHELIAL-CELLS

      The Journal of biological chemistry
    29. CHEN YQ; SU M; WALIA RR; HAO Q; COVINGTON JW; VAUGHAN DE
      SP1 SITES MEDIATE ACTIVATION OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1PROMOTER BY GLUCOSE IN VASCULAR SMOOTH-MUSCLE CELLS

      The Journal of biological chemistry
    30. BROWN NJ; VAUGHAN DE
      PRODRUG ACE-INHIBITORS - RESPONSE

      Circulation
    31. EREN M; VAUGHAN DE
      ANGIOTENSIN-II AND ANGIOTENSIN-IV INDUCE PAI-1 EXPRESSION THROUGH A SHARED PROMOTER ELEMENT

      Circulation
    32. BROWN NJ; CHEN YQ; VAUGHAN DE
      SYNERGISTIC EFFECT OF ALDO AND ANG-II ON PAI-1 EXPRESSION

      Circulation
    33. DALEY WL; PLAVIN S; VAUGHAN DE
      THE INDUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 BY THE HEXAPEPTIDE-(3-8) FRAGMENT OF THE RENIN-ANGIOTENSIN SYSTEM IS NOT PRESSOR DEPENDENT

      Circulation
    34. BU X; SU M; COVINGTON JW; QUERTERMOUS T; VAUGHAN DE
      ESTROGEN-RECEPTORS (ER-ALPHA AND ER-BETA) DOWN-REGULATE ET-1 GENE-EXPRESSION THROUGH GATA AND AP-1 SITES IN ENDOTHELIAL-CELLS

      Circulation
    35. BROWN NJ; VAUGHAN DE
      ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS

      Circulation
    36. AGIRBASLI M; VAUGHAN DE
      THE RENIN-ANGIOTENSIN SYSTEM AND VASCULAR FIBRINOLYTIC BALANCE

      International journal of clinical practice
    37. VENKOV CD; SU M; SHYR Y; VAUGHAN DE
      ETHANOL-INDUCED ALTERATIONS IN THE EXPRESSION OF ENDOTHELIAL-DERIVED FIBRINOLYTIC COMPONENTS

      Fibrinolysis & proteolysis
    38. RIDKER PM; BAKER MT; HENNEKENS CH; STAMPFER MJ; VAUGHAN DE
      ALU-REPEAT POLYMORPHISM IN THE GENE CODING FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND RISKS OF MYOCARDIAL-INFARCTION AMONG MIDDLE-AGED MEN

      Arteriosclerosis, thrombosis, and vascular biology
    39. LANG RM; ELKAYAM U; YELLEN LG; KRAUSS D; MCKELVIE RS; VAUGHAN DE; NEY DE; MAKRIS L; CHANG PI
      COMPARATIVE EFFECTS OF LOSARTAN AND ENALAPRIL ON EXERCISE CAPACITY AND CLINICAL STATUS IN PATIENTS WITH HEART-FAILURE

      Journal of the American College of Cardiology
    40. DALEY WL; PLAVIN S; VAUGHAN DE
      ENDOGENOUS INDUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR IN RABBITS BYANGIOTENSIN-II AND ITS HEXAPEPTIDE-(3-8) FRAGMENT

      Journal of the American College of Cardiology
    41. PERKINS WR; VAUGHAN DE; PLAVIN SR; DALEY WL; RAUCH J; LEE L; JANOFF AS
      STREPTOKINASE ENTRAPMENT IN INTERDIGITATION-FUSION LIPOSOMES IMPROVESTHROMBOLYSIS IN AN EXPERIMENTAL RABBIT MODEL

      Thrombosis and haemostasis
    42. BROWN NJ; NADEAU JH; VAUGHAN DE
      SELECTIVE STIMULATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) IN-VIVO BY INFUSION OF BRADYKININ

      Thrombosis and haemostasis
    43. TYNES HC; SU M; WASHINGTON K; KERINS DM; VAUGHAN DE; RUSSELL WE
      LIVER-REGENERATION IS DELAYED IN UROKINASE-DEFICIENT MICE

      Hepatology
    44. LITCHFIELD WR; VAUGHAN DE; BROWN NJ; WYCKOFF JA; WEISS RJ; WILLIAMS GH
      ACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM THROUGH DIETARY-SODIUM RESTRICTION INCREASES PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-I LEVELS IN ESSENTIAL-HYPERTENSION

      Hypertension
    45. BROWN NJ; VAUGHAN DE
      ACE-INHIBITION DECREASES PAI-1 IN THE SETTING OF AN ACTIVATED RAS

      Hypertension
    46. VAUGHAN DE
      ENDOTHELIAL FUNCTION, FIBRINOLYSIS, AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITION

      Clinical cardiology
    47. OIKAWA T; FREEMAN M; LO W; VAUGHAN DE; FOGO A
      MODULATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN-VIVO - A NEW MECHANISM FOR THE ANTI-FIBROTIC EFFECT OF RENIN-ANGIOTENSIN INHIBITION

      Kidney international
    48. CHEN YQ; WALIA RR; SU M; HAO Q; COVINGTON JW; VAUGHAN DE
      SP-1 SITES MEDIATE GLUCOSE ACTIVATION OF THE PLASMINOGEN-ACTIVATOR-INHIBITOR-1 (PAI-1) PROMOTER IN VASCULAR SMOOTH-MUSCLE CELLS

      Circulation
    49. STEIN CM; BROWN NJ; VAUGHAN DE; LANG CC; WOOD AJ
      VASCULAR REGULATION OF TISSUE-PLASMINOGEN ACTIVATOR RELEASE

      Circulation
    50. KERINS DM; GIBSON DW; SU M; HAO Q; VAUGHAN DE
      BRADYKININ RESULTS IN AN INCREASE IN T-PA EXPRESSION VIA A NITRIC-OXIDE INDEPENDENT PATHWAY

      Circulation
    51. KERINS DM; TANG H; HAO Q; VAUGHAN DE
      UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR-MEDIATED TYROSINE PHOSPHORYLATION OF FOCAL ADHESION PROTEINS AND ACTIVATION OF MAP KINASE IN CULTURED ENDOTHELIAL-CELLS

      Circulation
    52. VAUGHAN DE; ROULEAU JL; RIDKER PM; ARNOLD JMO; MENAPACE FJ; PFEFFER MA
      EFFECTS OF RAMIPRIL ON PLASMA FIBRINOLYTIC BALANCE IN PATIENTS WITH ACUTE ANTERIOR MYOCARDIAL-INFARCTION

      Circulation
    53. MCCONNELL MV; VAVOURANAKIS I; WU LL; VAUGHAN DE; RIDKER PM
      EFFECTS OF A SINGLE, DAILY ALCOHOLIC BEVERAGE ON LIPID AND HEMOSTATICMARKERS OF CARDIOVASCULAR RISK

      The American journal of cardiology
    54. VAUGHAN DE
      THE RENIN-ANGIOTENSIN SYSTEM AND FIBRINOLYSIS

      The American journal of cardiology
    55. BROWN NJ; VAUGHAN DE
      THE RENIN-ANGIOTENSIN AND FIBRINOLYTIC SYSTEMS - CO-CONSPIRATORS IN THE PATHOGENESIS OF ISCHEMIC CARDIOVASCULAR-DISEASE

      Trends in cardiovascular medicine
    56. OIKAWA T; FREEMAN M; LO W; VAUGHAN DE; FOGO A
      MODULATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN-VIVO - A NEW MECHANISM FOR THE ANTI-FIBROTIC EFFECT OF RENIN-ANGIOTENSIN INHIBITION

      Journal of the American Society of Nephrology
    57. LEE E; VAUGHAN DE; PARIKH SH; GRODZINSKY AJ; LIBBY P; LARK MW; LEE RT
      REGULATION OF MATRIX METALLOPROTEINASES AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 SYNTHESIS BY PLASMINOGEN IN CULTURED HUMAN VASCULAR SMOOTH-MUSCLE CELLS

      Circulation research
    58. BAKER MT; VAUGHAN DE; HENNEKENS CH; STAMPFER MJ; RIDKER PM
      POLYMORPHISM IN THE GENE CODING FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR(T-PA) AND RISK OF FUTURE MYOCARDIAL-INFARCTION

      Circulation
    59. VAUGHAN DE; COVINGTON J; HAO Q; KOURTEVA I
      THE HEXAPEPTIDE ANGIOTENSIN-IV BINDS TO A NONCLASSICAL ANGIOTENSIN RECEPTOR AND PROMOTES PHOSPHORYLATION OF MITOGEN-ACTIVATED PROTEIN-KINASE IN ENDOTHELIAL-CELLS

      Circulation
    60. VENKOV CD; RANKIN AB; VAUGHAN DE
      IDENTIFICATION OF AUTHENTIC ESTROGEN-RECEPTOR IN CULTURED ENDOTHELIAL-CELLS - A POTENTIAL MECHANISM FOR STEROID-HORMONE REGULATION OF ENDOTHELIAL FUNCTION

      Circulation
    61. VAUGHAN DE; ROULEAU JL; PFEFFER MA
      ROLE OF THE FIBRINOLYTIC SYSTEM IN PREVENTING MYOCARDIAL-INFARCTION

      European heart journal
    62. SIMON DI; XU H; VAUGHAN DE
      CATHEPSIN D-LIKE ASPARTYL PROTEASE ACTIVITY MEDIATES THE DEGRADATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1COMPLEXES IN HUMAN MONOCYTES

      Biochimica et biophysica acta. Molecular cell research
    63. RIDKER PM; VAUGHAN DE; STAMPFER MJ; GLYNN RJ; HENNEKENS CH
      ALCOHOL-CONSUMPTION AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR - REPLY

      JAMA, the journal of the American Medical Association
    64. RIDKER PM; VAUGHAN DE
      HEMOSTATIC FACTORS AND THE RISK OF MYOCARDIAL-INFARCTION

      The New England journal of medicine
    65. VAUGHAN DE; LAZOS SA; TONG K
      ANGIOTENSIN-II REGULATES THE EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN CULTURED ENDOTHELIAL-CELLS - A POTENTIAL LINK BETWEEN THE RENIN-ANGIOTENSIN SYSTEM AND THROMBOSIS

      The Journal of clinical investigation
    66. BROWN NJ; NADEAU J; VAUGHAN DE
      BRADYKININ INCREASES TISSUE-PLASMINOGEN ACTIVATOR IN HUMANS

      Circulation
    67. VENKOV CD; RANKIN AB; VAUGHAN DE
      ENDOTHELIAL-CELLS EXPRESS ESTROGEN-RECEPTOR - EVIDENCE FOR A FULL-LENGTH MESSENGER-RNA

      Circulation
    68. KERINS DM; HAO Q; NAFTILAN AJ; VAUGHAN DE
      UROKINASE-INDUCED GENE-EXPRESSION IN CULTURED HUMAN ENDOTHELIAL-CELLS

      Circulation
    69. BROWN NJ; GAINER JV; NADEAU JH; VAUGHAN DE
      PLASMINOGEN-ACTIVATOR INHIBITOR ANTIGEN IS INCREASED IN HYPERTENSIVE AFRICAN-AMERICANS WITH THE ACE D-ALLELE

      Circulation
    70. RIDKER PM; VAUGHAN DE; STAMPFER MJ; HENNEKENS CH
      SMOKING AND PLASMA-LEVEL OF ENDOGENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR

      Circulation
    71. VAUGHAN DE; PFEFFER MA
      POSTMYOCARDIAL INFARCTION VENTRICULAR REMODELING - ANIMAL AND HUMAN STUDIES

      Cardiovascular drugs and therapy
    72. RIDKER PM; HENNEKENS CH; STAMPFER MJ; MANSON JE; VAUGHAN DE
      PROSPECTIVE-STUDY OF ENDOGENOUS-TISSUE PLASMINOGEN-ACTIVATOR AND RISKOF STROKE

      Lancet
    73. RIDKER PM; VAUGHAN DE; STAMPFER MJ; GLYNN RJ; HENNEKENS CH
      ASSOCIATION OF MODERATE ALCOHOL-CONSUMPTION AND PLASMA-CONCENTRATION OF ENDOGENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR

      JAMA, the journal of the American Medical Association
    74. WANG XL; VAUGHAN DE; PELEKHATY V; CRISP J
      A NOVEL MINIATURE SPECTROMETER USING AN INTEGRATED ACOUSTOOPTIC TUNABLE FILTER

      Review of scientific instruments
    75. VAUGHAN DE; LAZOS SA; TONG K
      ENDOTHELIAL ANGIOTENSIN RECEPTOR - PHARMACOLOGICAL CHARACTERIZATION AND ROLE IN FIBRINOLYTIC REGULATION

      Circulation
    76. VAUGHAN DE; LAZOS SA; TONG K
      ENDOTHELIAL ANGIOTENSIN RECEPTOR - PHARMACOLOGICAL CHARACTERIZATION AND ROLE IN FIBRINOLYTIC REGULATION

      Circulation
    77. RIDKER PM; VAUGHAN DE; STAMPFER MJ; GLYNN RJ; HENNEKENS CH
      ALCOHOL-CONSUMPTION AND PLASMA-CONCENTRATION OF ENDOGENOUS-TISSUE PLASMINOGEN-ACTIVATOR

      Circulation
    78. RIDKER PM; VAUGHAN DE; STAMPFER MJ; GLYNN RJ; HENNEKENS CH
      ALCOHOL-CONSUMPTION AND PLASMA-CONCENTRATION OF ENDOGENOUS-TISSUE PLASMINOGEN-ACTIVATOR

      Circulation
    79. LEE E; VAUGHAN DE; PARIKH SH; GRODZINSKY AJ; LIBBY P; LARK MW; LEE RT
      MATRIX METALLOPROTEINASE PRODUCTION AND ACTIVATION BY HUMAN VASCULAR SMOOTH-MUSCLE CELLS IS REGULATED BY PLASMINOGEN

      Circulation
    80. LEE E; VAUGHAN DE; PARIKH SH; GRODZINSKY AJ; LIBBY P; LARK MW; LEE RT
      MATRIX METALLOPROTEINASE PRODUCTION AND ACTIVATION BY HUMAN VASCULAR SMOOTH-MUSCLE CELLS IS REGULATED BY PLASMINOGEN

      Circulation
    81. VENKOV CD; BROWN MA; VAUGHAN DE
      IDENTIFICATION OF ESTROGEN-RECEPTORS IN CULTURED ENDOTHELIAL-CELLS

      Circulation
    82. VENKOV CD; BROWN MA; VAUGHAN DE
      IDENTIFICATION OF ESTROGEN-RECEPTORS IN CULTURED ENDOTHELIAL-CELLS

      Circulation
    83. SIMON DI; XU H; VAUGHAN DE
      CATHEPSIN-D MEDIATES THE DEGRADATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1 COMPLEXES IN MONOCYTES

      Circulation
    84. SIMON DI; XU H; VAUGHAN DE
      CATHEPSIN-D MEDIATES THE DEGRADATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1 COMPLEXES IN MONOCYTES

      Circulation
    85. VAUGHAN DE; PFEFFER MA
      ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AND CARDIOVASCULAR REMODELING

      Cardiovascular Research
    86. RIDKER PM; VAUGHAN DE; STAMPFER MJ; SACKS FM; HENNEKENS CH
      A CROSS-SECTIONAL STUDY OF ENDOGENOUS-TISSUE PLASMINOGEN-ACTIVATOR, TOTAL CHOLESTEROL, HDL CHOLESTEROL, AND APOLIPOPROTEIN-A-I,A-II, AND B-100

      Arteriosclerosis and thrombosis
    87. LI XK; VAUGHAN DE
      CLONING OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR (U-PAR) CDNAFROM A HUMAN PLATELET LIBRARY

      Thrombosis and haemostasis
    88. RIDKER PM; VAUGHAN DE; STAMPFER MJ; MANSON JE; HENNEKENS CH
      A PROSPECTIVE-STUDY OF ENDOGENOUS-TISSUE PLASMINOGEN-ACTIVATOR (TPA) AND THE RISK OF FUTURE MYOCARDIAL-INFARCTION

      Thrombosis and haemostasis
    89. RIDKER PM; VAUGHAN DE; STAMPFER MJ; MANSON JE; HENNEKENS CH
      ENDOGENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION

      Lancet
    90. RIDKER PM; GABOURY CL; CONLIN PR; SEELY EW; WILLIAMS GH; VAUGHAN DE
      STIMULATION OF PLASMINOGEN-ACTIVATOR INHIBITOR INVIVO BY INFUSION OF ANGIOTENSIN-II - EVIDENCE OF A POTENTIAL INTERACTION BETWEEN THE RENIN-ANGIOTENSIN SYSTEM AND FIBRINOLYTIC FUNCTION

      Circulation
    91. VAUGHAN DE; DECLERCK PJ; REILLY TM; PARK K; COLLEN D; FASMAN GD
      DYNAMIC STRUCTURAL AND FUNCTIONAL-RELATIONSHIPS IN RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR-1 (RPAI-1)

      Biochimica et biophysica acta
    92. VAUGHAN DE; BRAUNWALD E
      FRONT-LOADED ACCELERATED INFUSIONS OF TISSUE PLASMINOGEN-ACTIVATOR - PUTTING A BETTER FOOT FORWARD

      Journal of the American College of Cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 03:45:45